Hubei Bio-pharmaceutical Industrial Technological Institute Inc.

This early-stage study tests a new ointment called HW211026 for actinic keratosis, rough patches on skin caused by sun damage. The main goal is to check if the ointment is safe and how the body handles it. About 40 adults with mild to moderate actinic keratosis on the face will a…

This early-phase study tests the safety and tolerability of a single dose of HW241045 in 56 healthy adults aged 18-55. Participants are randomly assigned to receive either the drug or a placebo, and researchers monitor for side effects. The goal is to gather initial safety data b…